Arcturus Therapeutics Holdings Inc. (ARCT) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arcturus Therapeutics Holdings Inc. logo
ARCT
Arcturus Therapeutics Holdings Inc.
$369M
$13.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$436M
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ARCT vs YDES

growth of $100 · dividends reinvested · last 1y
ARCT +20.2% (+20.2%/yr)YDES -40.9% (-40.9%/yr)ARCT compounded faster over this window
50100150200Start $1002026$120$59
ARCT YDES

ARCT vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $369M market cap).
  • •Both run net losses; ARCT's is the smaller (-391.90% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricARCTYDES
P/S ratio15.52N/A
P/B ratio2.15N/A

Profitability

MetricARCTYDES
Gross margin95.50%-7.06%
Operating margin-111.51%-883.31%
Net margin-391.90%-1392.61%
ROE-54.29%-66.49%
ROIC-54.07%N/A

Growth (annualized)

MetricARCTYDES
Revenue CAGR (5Y)22.30%N/A
Total return CAGR (5Y)-18.73%N/A

Go deeper

Full ARCT analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

Arcturus Therapeutics ROEYD Bio Limited Ordinary Shares ROEArcturus Therapeutics operating marginYD Bio Limited Ordinary Shares operating marginArcturus Therapeutics revenue growthYD Bio Limited Ordinary Shares revenue growthArcturus Therapeutics free cash flowYD Bio Limited Ordinary Shares free cash flow

Arcturus Therapeutics & YD Bio Limited Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.